Medicare Enrolled
Dr. Nitin Chhabra, M.D.
Pain Medicine · Dalton, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chhabra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chhabra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chhabra
Dr. Nitin Chhabra is a pain medicine specialist in Dalton, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chhabra performed 5,791 Medicare services across 1,777 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chhabra received a total of $10,809 from 58 pharmaceutical and/or device companies across 579 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chhabra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in GA
$10,809 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,791
Medicare services
Top 4% in GA for pain medicine
1,777
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~305 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,417 | $88 | $242 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,201 | $0 | $5 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
744 | $0 | $31 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
634 | $60 | $378 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
617 | $112 | $575 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
479 | $10 | $60 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
110 | $1 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
108 | $57 | $197 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
95 | $70 | $1,424 |
| Orphenadrine injection, up to 60 mg An injection of orphenadrine citrate administered in a dose of up to 60 milligrams. |
88 | $4 | $31 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
63 | $83 | $2,910 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
50 | $50 | $727 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
43 | $79 | $1,430 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
36 | $116 | $2,650 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
33 | $60 | $1,269 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
32 | $200 | $2,682 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
28 | $53 | $1,325 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $124 | $424 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,809
Total received (2018-2024)
Avg $1,544/year across 7 years
Top 11% in GA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
579
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,809 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,111
2023
$730
2022
$1,627
2021
$1,942
2020
$1,375
2019
$1,682
2018
$2,341
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$392
Medtronic, Inc.
$188
Collegium Pharmaceutical, Inc.
$161
SPINEFRONTIER, INC.
$145
Averitas Pharma Inc.
$90
SCILEX PHARMACEUTICALS INC.
$50
ConvaTec Inc.
$26
Abbott Laboratories
$21
Nalu Medical, Inc.
$21
Forte Bio-Pharma LLC
$18
Top 3 companies account for 66.6% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$2,138
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,399
BOSTON SCIENTIFIC CORPORATION
$1,090
Nevro Corp.
$734
Collegium Pharmaceutical, Inc.
$708
Abbott Laboratories
$675
Amgen Inc.
$477
PFIZER INC.
$227
Medtronic, Inc.
$210
Indivior Inc.
$179
Purdue Pharma L.P.
$175
Sentynl Therapeutics, Inc.
$166
RedHill Biopharma Inc.
$165
SCILEX PHARMACEUTICALS INC.
$159
SPINEFRONTIER, INC.
$145
Flexion Therapeutics, Inc.
$143
ABBVIE INC.
$121
Scilex Pharmaceuticals Inc.
$120
Takeda Pharmaceuticals U.S.A., Inc.
$100
Forte Bio-Pharma LLC
$99
Averitas Pharma Inc.
$90
Daiichi Sankyo Inc.
$86
Pernix Therapeutics Holdings, Inc.
$80
Teva Pharmaceuticals USA, Inc.
$76
Eisai Inc.
$76
AbbVie Inc.
$70
Biohaven Pharmaceuticals, Inc.
$64
GRT US Holding, Inc.
$63
BioDelivery Sciences International, Inc.
$58
AstraZeneca Pharmaceuticals LP
$53
Lundbeck LLC
$50
Egalet US Inc
$49
Nuvectra Corporation
$48
IBSA Pharma Inc.
$47
Shionogi Inc
$46
Hikma Pharmaceuticals USA
$46
Orexo US, Inc.
$44
Zyla Life Sciences
$42
INSYS Therapeutics Inc
$42
Novartis Pharmaceuticals Corporation
$41
Almatica Pharma LLC
$39
Pacira Therapeutics, Inc.
$32
Aytu BioScience, Inc
$32
SANOFI-AVENTIS U.S. LLC
$31
Medtronic USA, Inc.
$30
Assertio Therapeutics, Inc.
$29
ARBOR PHARMACEUTICALS, INC.
$28
ASSERTIO THERAPEUTICS, Inc.
$27
ConvaTec Inc.
$26
Nalu Medical, Inc.
$21
Upsher-Smith Laboratories LLC
$18
Allergan, Inc.
$16
Merck Sharp & Dohme LLC
$16
SI-BONE, INC.
$15
Merck Sharp & Dohme Corporation
$13
Horizon Pharma plc
$12
Currax Pharmaceuticals LLC
$12
Supernus Pharmaceuticals, Inc.
$11
Top 3 companies account for 42.8% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AQUACEL AG+ EXTRA · ARYMO ER · Aimovig · Algovita · Amitiza · BELBUCA · BELSOMRA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · CONTRAVE · Dayvigo · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · General - Pain Management · General - Vascular Access · Gralise · HYSINGLA ER · Horizant · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · Kloxxado · LICART · LINEAR · LUCEMYRA · LYRICA · Levorphanol · Levorphanol Tartrate · Licart · MOVANTIK · Morphabond ER · Movantik · NALOCET · NAPRELAN · NURTEC ODT · Nalocet · Nalu Neurostimulation System · Natesto · PENNSAID · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · REYVOW · Ryaltris · SIJFuse · SPECTRA WAVEWRITER · SPRIX · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUBSYS · SYMPROIC · SYNDROS · SYNVISC-ONE · Senza Spinal Cord Stimulation System · Superion Indirect Decompression System · Symproic · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · UBRELVY · VYEPTI · WAVEWRITER ALPHA · XTAMPZA · XTAMPZAER · Xtampza ER · XtampzaER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicines within 10 mi
4
Per 100K population
3.9
County median income
$64,262
Nearest hospital
HAMILTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chhabra is a clinical cardiology specialist, with above-average Medicare volume (top 4% in GA), with low-engagement industry engagement in the top 11% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chhabra experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chhabra performed 1,417 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chhabra receive payments from pharmaceutical companies?
Yes. Dr. Chhabra received a total of $10,809 from 58 companies across 579 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chhabra's costs compare to other pain medicines in Dalton?
Dr. Chhabra's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chhabra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Dalton
Browse pain medicines in Dalton ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in GA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in GA
Which GA pain medicines receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology